Dianne Seigers

Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trial.

J. Vonk, H. Kerstjens, O. Carpaij, 2020, Respiratory medicine.

Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD

J. Vonk, H. Kerstjens, B. Kroesen, 2023, Thorax.